Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Nature of expenses - Research and development (Details)

v3.19.3.a.u2
Nature of expenses - Research and development (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Expenses by nature [abstract]    
Contract research organizations (CROs) and other third party clinical trial expenses $ 29,100 $ 27,923
Drug supply and distribution 13,355 4,893
Salaries, incentive pay and employee benefits 5,906 4,260
Stock compensation expense 2,693 2,697
Travel, insurance, patent annuity fees, legal fees and other 1,812 1,609
Research and development expense $ 52,866 $ 41,382